191 related articles for article (PubMed ID: 24403231)
1. Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.
Prudnikova TY; Soulitzis N; Kutsenko OS; Mostovich LA; Haraldson K; Ernberg I; Kashuba VI; Spandidos DA; Zabarovsky ER; Grigorieva EV
Cancer Med; 2013 Oct; 2(5):654-61. PubMed ID: 24403231
[TBL] [Abstract][Full Text] [Related]
2. D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.
Rosenberg EE; Prudnikova TY; Zabarovsky ER; Kashuba VI; Grigorieva EV
Tumour Biol; 2014 Apr; 35(4):3237-45. PubMed ID: 24264315
[TBL] [Abstract][Full Text] [Related]
3. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
[TBL] [Abstract][Full Text] [Related]
4. miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues.
Prudnikova TY; Mostovich LA; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Oct; 7(10):1109-14. PubMed ID: 22968430
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of human D-glucuronyl C5-epimerase in breast cancer.
Grigorieva E; Eshchenko T; Rykova VI; Chernakov A; Zabarovsky E; Sidorov SV
Int J Cancer; 2008 Mar; 122(5):1172-6. PubMed ID: 17985344
[TBL] [Abstract][Full Text] [Related]
6. D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.
Grigorieva EV; Prudnikova TY; Domanitskaya NV; Mostovich LA; Pavlova TV; Kashuba VI; Zabarovsky ER
Br J Cancer; 2011 Jun; 105(1):74-82. PubMed ID: 21654676
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
[TBL] [Abstract][Full Text] [Related]
8. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
9. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
10. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of EphA5 by promoter methylation in human prostate cancer.
Li S; Zhu Y; Ma C; Qiu Z; Zhang X; Kang Z; Wu Z; Wang H; Xu X; Zhang H; Ren G; Tang J; Li X; Guan M
BMC Cancer; 2015 Jan; 15():18. PubMed ID: 25609195
[TBL] [Abstract][Full Text] [Related]
12. GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.
Belyavskaya VA; Prudnikova TY; Domanitskaya NV; Litviakov NV; Maksimov VN; Cherdyntseva NV; Grigorieva EV
Gene; 2017 Sep; 628():224-229. PubMed ID: 28734894
[TBL] [Abstract][Full Text] [Related]
13. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.
Chang G; Xu S; Dhir R; Chandran U; O'Keefe DS; Greenberg NM; Gingrich JR
Clin Cancer Res; 2010 Nov; 16(22):5390-401. PubMed ID: 21062931
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
Khor TO; Fuentes F; Shu L; Paredes-Gonzalez X; Yang AY; Liu Y; Smiraglia DJ; Yegnasubramanian S; Nelson WG; Kong AN
Cancer Prev Res (Phila); 2014 Dec; 7(12):1186-97. PubMed ID: 25266896
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells.
Prudnikova TY; Mostovich LA; Domanitskaya NV; Pavlova TV; Kashuba VI; Zabarovsky ER; Grigorieva EV
Cancer Cell Int; 2010 Aug; 10():27. PubMed ID: 20723247
[TBL] [Abstract][Full Text] [Related]
17. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
18. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.
Mitsui Y; Chang I; Kato T; Hashimoto Y; Yamamura S; Fukuhara S; Wong DK; Shiina M; Imai-Sumida M; Majid S; Saini S; Shiina H; Nakajima K; Deng G; Dahiya R; Tanaka Y
Oncotarget; 2016 Aug; 7(31):49107-49121. PubMed ID: 27203547
[TBL] [Abstract][Full Text] [Related]
19. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
